Published in Medical Letter on the CDC and FDA, February 25th, 2007
Betahistine is currently marketed in many countries for the treatment of vertigo. The drug was first approved in the mid 1960's but was taken off the U.S. market by the U.S. Food & Drug Administration for lack of clinical evidence in that indication. Notably, no safety issues were raised and a recent...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.